SEC 13F Intelligence

Propel Bio Management, LLC / KURA

Propel Bio Management, LLC’s Kura Oncology Inc Position

Does Propel Bio Management, LLC own Kura Oncology Inc (KURA)? Not currently — the last reported position was 130.0K shares worth $1M in Q4 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$1M
Q4 2024
Shares
130.0K
% of Portfolio
+1.12%
Quarters Held
5
position exited

Position History KURA

Reported value by quarter
Q4 ’23: $2MQ4 ’23Q1 ’24: $3MQ1 ’24Q2 ’24: $3MQ2 ’24Q3 ’24: $3MQ3 ’24Q4 ’24: $1MQ4 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2024130.0K$1M+1.12%
Q3 2024130.0K$3M+1.47%
Q2 2024130.0K$3M+1.74%
Q1 2024130.0K$3M+1.61%
Q4 2023130.0K$2M+1.55%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Propel Bio Management, LLC’s full portfolio or all institutional holders of KURA.